|
Volumn 42, Issue 3, 2012, Pages 163-164
|
Plasmodium vivax remains responsive to chloroquine with primaquine treatment regimen: A prospective cohort study from tertiary care teaching hospital in southern India
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTEMISININ;
CHLOROQUINE;
GLUCOSE 6 PHOSPHATE DEHYDROGENASE;
PRIMAQUINE;
AMINOTRANSFERASE;
ARTESUNATE;
ADULT;
AMINOTRANSFERASE BLOOD LEVEL;
ANEMIA;
ARTICLE;
BLOOD BUFFY COAT;
BLOOD CELL COUNT;
BLOOD SAMPLING;
CLINICAL FEATURE;
CLINICAL TRIAL (TOPIC);
COHORT ANALYSIS;
DIAGNOSTIC TEST;
FEMALE;
FEVER;
FOLLOW UP;
HEPATOMEGALY;
HUMAN;
HYPERBILIRUBINEMIA;
HYPOTENSION;
INDIA;
INFORMED CONSENT;
JAUNDICE;
KIDNEY FAILURE;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MIXED INFECTION;
OBSERVATIONAL STUDY;
PARASITE CLEARANCE;
PLASMODIUM VIVAX;
PLASMODIUM VIVAX MALARIA;
PROSPECTIVE STUDY;
SPLENOMEGALY;
TEACHING HOSPITAL;
THROMBOCYTOPENIA;
TREATMENT RESPONSE;
TERTIARY HEALTH CARE;
TREATMENT DURATION;
ADULT;
ANTIMALARIALS;
CHLOROQUINE;
COHORT STUDIES;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALARIA, VIVAX;
MALE;
PLASMODIUM VIVAX;
PRIMAQUINE;
PROSPECTIVE STUDIES;
TERTIARY CARE CENTERS;
TREATMENT OUTCOME;
YOUNG ADULT;
PLASMODIUM VIVAX;
|
EID: 84864056035
PISSN: 00494755
EISSN: 17581133
Source Type: Journal
DOI: 10.1258/td.2012.120038 Document Type: Article |
Times cited : (3)
|
References (8)
|